AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
6645.T

OMRON Corporation (6645.T) fair value

Technology · Electronic Components · TSE · Japan
¥5330.00-3.07%
Market cap ¥1.05TNext earnings 2026-11-10Updated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionOMRON Corporation (6645.T)
Fair value
Not available
ACCE price target
¥5690
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: ¥5330 at the close on 23 Oct 2026, 08:30 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
64
out of 100
P/E
26.1x
forward 19.7x
1-year return
+22.8%
Dividend yield
1.89%

OMRON Corporation in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

OMRON makes industrial automation hardware: programmable logic controllers, motion controllers, safety sensors, and factory-floor vision and inspection systems, alongside a healthcare arm that sells blood pressure monitors and digital health services. Its edge is a long installed base in factory automation, where switching a PLC or sensor platform means reengineering production lines, which gives it sticky recurring demand for replacement and expansion. Revenue grew 10.8% recently, and the stock trades at 20.3x forward earnings against 27.1x trailing, implying the market expects earnings to recover from a weaker base. The ROE of 5.1% and operating margin of 9.0% are thin, so the thesis rests on whether factory automation demand and margin recovery show up in the next few reporting periods. Worth a deeper look to test the margin path and the cyclicality of its industrial exposure.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where 6645.T's valuation models land
Price
¥5330.00
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-9.0%
1 month
-13.6%
3 months
-2.7%
6 months
+4.7%
YTD
+34.6%
1 year
+22.8%

Held by ETFs

ETFs we cover that hold OMRON Corporation among their largest holdings, by weight.

  • BOTZ · Global X Robotics & AI ETF2.0% of the fund
Holdings as of 2026-10-24

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target¥5690first publication¥5499

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in JPY. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full 6645.T page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value49Quality60Momentum70Total64
Valuation
Trailing P/E
26.1x
Forward P/E
19.7x
PEG
0.47
P/B
no data
EV / Revenue
no data
Book value/sh
no data
Enterprise value
no data
Profitability
ROE
5.1%
FCF yield
-6.17%
ROIC
no data
Health and risk
Debt / equity
0.32
Dividend yield
1.89%
Beta
no data

Price

+20.0% · 1Y

Ask anything about 6645.T

Answered from OMRON Corporation fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 0.0x26.1xhigh 101.5x
ROEbetter than 20% of peers
low -54%5%high 19%
Div yieldbetter than 83% of peers
low 0.0%1.9%high 1.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
6645.T OMRON Corporation¥5330.00--26.1x5.1%6064
6976.T Taiyo Yuden Co., Ltd.¥8364.00--64.7x5.3%4857
RAL Ralliant Corporation Common Stock$66.49$5914% above--53.9%4865
ATS.VI AT & S Austria Technologie & Systemtechnik Aktiengesellschaft€139.00€9153% above101.5x5.9%4263
4186.T Tokyo Ohka Kogyo Co., Ltd.¥7735.00--24.6x19.4%8063
PLXS Plexus Corp. Common Stock$216.98$14549% above32.1x12.6%5351
6479.T MINEBEA MITSUMI Inc.¥3120.00--11.5x-5569

Sector report card

Where 6645.T ranks against its sector peers on each metric.

Computing percentiles…